Chronic TBI: A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury
Study Details
Study Description
Brief Summary
The aim of this research is to determine if the biological fluids (blood/saliva) from chronic brain-injured patients (both blast and non-penetrating TBI) contain reproducible protein markers. To accomplish this two populations of chronic TBI patients who are receiving treatment at The Institute for Research and Rehabilitation (TIRR): blast injury victims and non-penetrating TBI will be studied. Using multiple proteomic approaches including mass spectrometry, multiplex ELISAs, and antibody microarrays, as well as RNA profiling, the investigators aim to identify biomarkers in the blood/saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups. Identification of these biochemical changes will give insight into the long-lasting changes associated with head injury, and may identify new targets for treating the associated pathologies.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Chronic TBI Patients - Non-penetrating Chronic TBI patients should have a history of head trauma manifesting in one or more of the following: Loss of consciousness Post-traumatic amnesia Focal neurologic deficits, seizure Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance) Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.) Patients will be excluded from the study if we are unable to obtain informed consent and if they are non-communicative (i.e. in a vegetative state). |
Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)
|
Chronic TBI Patients - Blast Chronic TBI Blast injury patients should have a history of head trauma manifesting in one or more of the following: Loss of consciousness Post-traumatic amnesia Focal neurologic deficits, seizure Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance) Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.) Patients will be excluded from the study if we are unable to obtain informed consent and if they are non-communicative (i.e. in a vegetative state). |
Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)
|
Healthy Volunteers Healthy volunteers include gender, age and race matched volunteers able to provide informed consent who have, No significant medical history Take no medications (other than birth control pills) Fever free No history of head trauma or recent injury/infection No history of neurological or psychiatric disorders or alcohol or drug dependency. |
Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)
|
Outcome Measures
Primary Outcome Measures
- Proteomic analysis of plasma [average of 6 months post injury]
The aim is to identify biomarkers in the blood of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.
Secondary Outcome Measures
- Proteomic analysis of saliva [average of 6 months post injury]
The aim is to identify biomarkers in the saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.
Eligibility Criteria
Criteria
Chronic TBI patients:
Inclusion Criteria
Have a history of head trauma manifesting in one or more of the following:
-
Loss of consciousness
-
Post-traumatic amnesia
-
Focal neurologic deficits, seizure
-
Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance)
-
Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.)
Exclusion Criteria
Inability to obtain informed consent and if they are non-communicative (i.e. in a vegetative state).
Healthy volunteers:
Inclusion Criteria
-
No significant medical history
-
Take no medications (other than birth control pills)
-
Fever free
-
No history of head trauma or recent injury/infection
-
No history of neurological or psychiatric disorders or alcohol or drug dependency.
Exclusion Criteria
-
Inability to provide informed consent
-
age/gender match not available in TBI cohort
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | TIRR | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- The University of Texas Health Science Center, Houston
Investigators
- Principal Investigator: Georgene Hergenroeder, PhD, The University of Texas Health Science Center, Houston
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HSC-MS-09-0334